Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PORCN (Protein-serine O-palmitoleoyltransferase porcupine) is a multi-transmembrane enzyme located in the endoplasmic reticulum. It functions as a key regulator of the Wnt signaling pathway by mediating the post-translational attachment of palmitoleate, a 16-carbon monounsaturated fatty acid, to Wnt proteins. This lipid modification is essential for efficient binding of Wnt ligands to their frizzled receptors and subsequent signal transduction. Aberrant activation or dysregulation may contribute to cancer development. Mutations in PORCN cause focal dermal hypoplasia (Goltz syndrome).
Inhibition of WNT palmitoleoylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein-serine O-palmitoleoyltransferase porcupine (PORCN).